Publication:
Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin

dc.contributor.authorSawatpanich T.
dc.contributor.authorPetpiboolthai H.
dc.contributor.authorPunyarachun B.
dc.contributor.authorAnupunpisit V.
dc.date.accessioned2021-04-05T03:36:06Z
dc.date.available2021-04-05T03:36:06Z
dc.date.issued2010
dc.date.issuedBE2553
dc.description.abstractObjective: To localize and demonstrate the effect of curcumin on vascular endothelial growth factor in diabetic mice kidney induced by streptozotocin Material and Method: Diabetic mice were induced by streptozotocin (60 mg/kg BW). Male mice were divided into three groups, control mice, diabetic mice (DM) and diabetic mice treated with curcumin (DMC) (200 mg/ kg BW). At 4 and 8 weeks, animals were sacrificed and kidneys were processed by immunohistochemistry technique. Results: At the end of 4 and 8 week experiments, glomeruli were slightly enlarged and showed diffuse thickening of the glomerular capillary walls in diabetic mice. Administration with curcumin presented the better improvement and recovery of cells and tissues compared with diabetic mice. Immunohistochemical staining for vascular endothelial growth factor (VEGF) demonstrated that VEGF was mainly detected in the podocytes and renal tubules. There was an increase in VEGF expression in diabetic mice as compared to control. Treatment with curcumin significantly inhibited the expression of VEGF in the kidney tissue of diabetic mice in both 4 and 8 weeks. Comparing the diabetic mice between 4 and 8 week experiments, the expression of VEGF in the podocytes and renal tubules at 8 week were significantly stronger than at 4 week which represented time-dependent change. Nevertheless, the intensity of VEGF was not different in DMC mice when it was compared between 4 and 8 weeks. Conclusion: VEGF immunoreactivity of the podocytes and the renal tubules at 4 and 8 weeks in DM mice showed strong intensity more than in control mice. However, the intensity of VEGF in DMC mice was less when it was compared with DM mice. Moreover, VEGF was a key modulator of angiogenesis and a potent mitogen for endothelial cells. These results demonstrated the potential use of antiangiogenic curcumin as a novel therapeutic agent in diabetic mellitus and maintain normal structure of the kidney.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 93, No.SUPPL 2 (2010), p.S1-S8
dc.identifier.issn1252208
dc.identifier.other2-s2.0-79952274286
dc.identifier.urihttps://swu-dspace2.eval.plus/handle/123456789/7480
dc.rights.holderScopus
dc.subject.otherAngiogenesis inhibitor
dc.subject.otherAntineoplastic agent
dc.subject.otherAntineoplastic antibiotic
dc.subject.otherCurcumin
dc.subject.otherStreptozocin
dc.subject.otherVasculotropin
dc.subject.otherAnimal
dc.subject.otherArticle
dc.subject.otherChemically induced disorder
dc.subject.otherExperimental diabetes mellitus
dc.subject.otherGenetics
dc.subject.otherHyperglycemia
dc.subject.otherImmunohistochemistry
dc.subject.otherKidney
dc.subject.otherMale
dc.subject.otherMetabolism
dc.subject.otherPathology
dc.subject.otherRat
dc.subject.otherAngiogenesis Inhibitors
dc.subject.otherAnimals
dc.subject.otherAntibiotics, Antineoplastic
dc.subject.otherAntineoplastic Agents
dc.subject.otherCurcumin
dc.subject.otherDiabetes Mellitus, Experimental
dc.subject.otherHyperglycemia
dc.subject.otherImmunohistochemistry
dc.subject.otherKidney
dc.subject.otherMale
dc.subject.otherRats
dc.subject.otherStreptozocin
dc.subject.otherVascular Endothelial Growth Factors
dc.titleEffect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-79952274286&partnerID=40&md5=677b40e32c1db11536d27f77e4e89b02

Files